Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


FutureLearn and free courses: is this what students really want?

20 September 2013

By Prof Stephen Caddick, University College London
Moocs are an online product of current higher education offline, says Stephen Caddick – standardised and one-size-fits-all.

FutureLearn, the Open University's long awaited online learning platform, has finally gone live with great fanfare and partnerships with some of the UK's top universities. It's an exciting addition to a growing series of online ventures across the globe that are providing education to a mass audience, free-of-charge.

Read the full article in the Guardian